vs
Alpine Income Property Trust, Inc.（PINE）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是Alpine Income Property Trust, Inc.的1.9倍（$35.5M vs $18.4M），Alpine Income Property Trust, Inc.净利率更高（11.9% vs -304.2%，领先316.1%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 29.6%），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 21.4%）
Alpine Income Property Trust, Inc.是一家公开交易的房地产投资信托，持有并运营美国各地的单租户净租赁商业地产组合，核心资产板块包括民生零售、工业及郊区办公物业，通过稳定的经常性租金收入为股东提供持续回报。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
PINE vs RXRX — 直观对比
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $18.4M | $35.5M |
| 净利润 | $2.2M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | — | -304.8% |
| 净利率 | 11.9% | -304.2% |
| 营收同比 | 29.6% | 681.7% |
| 净利润同比 | 285.3% | 39.6% |
| 每股收益（稀释后） | $0.06 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q1 26 | $18.4M | — | ||
| Q4 25 | $16.9M | $35.5M | ||
| Q3 25 | $14.6M | $5.2M | ||
| Q2 25 | $14.9M | $19.2M | ||
| Q1 25 | $14.2M | $14.7M | ||
| Q4 24 | $13.8M | $4.5M | ||
| Q3 24 | $13.5M | $26.1M | ||
| Q2 24 | $12.5M | $14.4M |
| Q1 26 | $2.2M | — | ||
| Q4 25 | $1.5M | $-108.1M | ||
| Q3 25 | $-1.3M | $-162.3M | ||
| Q2 25 | $-1.6M | $-171.9M | ||
| Q1 25 | $-1.2M | $-202.5M | ||
| Q4 24 | $-958.0K | $-178.9M | ||
| Q3 24 | $3.1M | $-95.8M | ||
| Q2 24 | $204.0K | $-97.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% |
| Q1 26 | — | — | ||
| Q4 25 | 35.3% | -304.8% | ||
| Q3 25 | 16.6% | -3327.6% | ||
| Q2 25 | 16.8% | -916.8% | ||
| Q1 25 | 16.0% | -1297.9% | ||
| Q4 24 | 14.3% | -4042.4% | ||
| Q3 24 | 47.9% | -377.1% | ||
| Q2 24 | 24.0% | -697.4% |
| Q1 26 | 11.9% | — | ||
| Q4 25 | 8.7% | -304.2% | ||
| Q3 25 | -9.0% | -3135.3% | ||
| Q2 25 | -11.0% | -894.2% | ||
| Q1 25 | -8.3% | -1373.3% | ||
| Q4 24 | -6.9% | -3935.5% | ||
| Q3 24 | 22.8% | -367.5% | ||
| Q2 24 | 1.6% | -676.6% |
| Q1 26 | $0.06 | — | ||
| Q4 25 | $0.07 | $-0.17 | ||
| Q3 25 | $-0.09 | $-0.36 | ||
| Q2 25 | $-0.12 | $-0.41 | ||
| Q1 25 | $-0.08 | $-0.50 | ||
| Q4 24 | $-0.06 | $-0.56 | ||
| Q3 24 | $0.21 | $-0.34 | ||
| Q2 24 | $0.01 | $-0.40 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.6M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $312.5M | $1.1B |
| 总资产 | $745.1M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
| Q1 26 | $2.6M | — | ||
| Q4 25 | $4.6M | $743.3M | ||
| Q3 25 | $1.2M | $659.8M | ||
| Q2 25 | $5.0M | $525.1M | ||
| Q1 25 | $6.1M | $500.5M | ||
| Q4 24 | $1.6M | $594.4M | ||
| Q3 24 | $2.6M | $427.6M | ||
| Q2 24 | $3.3M | $474.3M |
| Q1 26 | — | — | ||
| Q4 25 | $377.7M | $9.6M | ||
| Q3 25 | $358.2M | $11.9M | ||
| Q2 25 | $352.6M | $14.2M | ||
| Q1 25 | $356.5M | $16.4M | ||
| Q4 24 | $301.5M | $19.0M | ||
| Q3 24 | $278.9M | $20.5M | ||
| Q2 24 | $268.3M | $22.9M |
| Q1 26 | $312.5M | — | ||
| Q4 25 | $279.9M | $1.1B | ||
| Q3 25 | $223.5M | $1.0B | ||
| Q2 25 | $229.8M | $919.1M | ||
| Q1 25 | $240.9M | $933.9M | ||
| Q4 24 | $253.0M | $1.0B | ||
| Q3 24 | $248.2M | $524.6M | ||
| Q2 24 | $244.0M | $584.4M |
| Q1 26 | $745.1M | — | ||
| Q4 25 | $715.9M | $1.5B | ||
| Q3 25 | $621.4M | $1.4B | ||
| Q2 25 | $628.4M | $1.3B | ||
| Q1 25 | $647.4M | $1.3B | ||
| Q4 24 | $605.0M | $1.4B | ||
| Q3 24 | $579.0M | $726.5M | ||
| Q2 24 | $565.8M | $775.9M |
| Q1 26 | — | — | ||
| Q4 25 | 1.35× | 0.01× | ||
| Q3 25 | 1.60× | 0.01× | ||
| Q2 25 | 1.53× | 0.02× | ||
| Q1 25 | 1.48× | 0.02× | ||
| Q4 24 | 1.19× | 0.02× | ||
| Q3 24 | 1.12× | 0.04× | ||
| Q2 24 | 1.10× | 0.04× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | — | $-47.3M |
| 自由现金流率自由现金流/营收 | — | -133.1% |
| 资本支出强度资本支出/营收 | — | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-378.3M |
8季度趋势，按日历期对齐
| Q1 26 | — | — | ||
| Q4 25 | $25.8M | $-46.1M | ||
| Q3 25 | $8.7M | $-117.4M | ||
| Q2 25 | $9.1M | $-76.4M | ||
| Q1 25 | $5.8M | $-132.0M | ||
| Q4 24 | $23.4M | $-115.4M | ||
| Q3 24 | $6.2M | $-59.2M | ||
| Q2 24 | $8.0M | $-82.2M |
| Q1 26 | — | — | ||
| Q4 25 | $-87.8M | $-47.3M | ||
| Q3 25 | $-48.8M | $-117.6M | ||
| Q2 25 | $-3.0M | $-79.6M | ||
| Q1 25 | $-55.5M | $-133.8M | ||
| Q4 24 | $-33.4M | $-116.7M | ||
| Q3 24 | $-43.0M | $-63.8M | ||
| Q2 24 | $-13.5M | $-83.4M |
| Q1 26 | — | — | ||
| Q4 25 | -519.4% | -133.1% | ||
| Q3 25 | -334.9% | -2272.5% | ||
| Q2 25 | -20.0% | -413.9% | ||
| Q1 25 | -391.0% | -907.4% | ||
| Q4 24 | -242.4% | -2567.7% | ||
| Q3 24 | -319.3% | -244.6% | ||
| Q2 24 | -108.0% | -578.5% |
| Q1 26 | — | — | ||
| Q4 25 | 671.8% | 3.5% | ||
| Q3 25 | 394.8% | 4.7% | ||
| Q2 25 | 81.2% | 16.4% | ||
| Q1 25 | 432.0% | 12.4% | ||
| Q4 24 | 412.3% | 28.6% | ||
| Q3 24 | 365.4% | 17.5% | ||
| Q2 24 | 172.3% | 8.2% |
| Q1 26 | — | — | ||
| Q4 25 | 17.48× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.02× | — | ||
| Q2 24 | 39.37× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PINE
| Lease Income | $12.6M | 68% |
| Other | $5.8M | 31% |
| Other Revenue | $46.0K | 0% |
RXRX
暂无分部数据
